Literature DB >> 8178762

Immunotyping of lymphoma by fine-needle aspiration. A comparative study of cytospin preparations and flow cytometry.

D B Robins1, R L Katz, F Swan, E N Atkinson, N G Ordonez, Y O Huh.   

Abstract

Immunotyping is an essential adjunct to cytomorphology for the diagnosis of lymphoma by fine-needle aspiration (FNA). Two independent techniques, cytospin preparations and flow cytometry, were used for immunotyping studies on 71 patients with histologically confirmed non-Hodgkin's lymphoma (63 B-cell lymphomas and 8 T-cell lymphomas). Diagnostic concordance between the two methods was obtained in 69 patients (97%). kappa, lambda, and CD3 (Leu-4) markers were routinely measured on all cytospins, and additional markers were requested when indicated. The standard panel measured by flow cytometry included 14 markers. In general, mean values of light-chain (kappa and lambda) immunoglobulins were consistently slightly higher by cytospin analysis than by flow cytometry. Light-chain immunoglobulin ratios (kappa/lambda or lambda/kappa) obtained by both methods proved to be reliable independent predictors of polyclonality or monoclonality. Correlation studies using the Spearman rank coefficient revealed good concordance among values of kappa, alpha, CD3, and CD5 obtained by the two techniques, suggesting that subjective quantitation by cytospins yields similar results to objective quantitation by flow cytometry. Cytospin analysis and flow cytometry appear equally capable of immunotyping aspirated lymphoid samples reliably. The advantages of each method are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 8178762     DOI: 10.1093/ajcp/101.5.569

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Role of polymerase chain reaction and immunocytochemistry in the cytological assessment of lymphoid proliferations.

Authors:  L Venkatraman; M A Catherwood; A Patterson; T F Lioe; W G McCluggage; N H Anderson
Journal:  J Clin Pathol       Date:  2006-03-13       Impact factor: 3.411

2.  Immunoglobulin light chain mRNA detected by in situ hybridisation in diagnostic fine needle aspiration cytology specimens.

Authors:  C J Stewart; M A Farquharson; T Kerr; J McCorriston
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

3.  Immunophenotyping by flow cytometry of fine needle aspirates in the diagnosis of lymphoproliferative disorders: A retrospective study.

Authors:  R M Henrique; M E Sousa; M I Godinho; I Costa; I L Barbosa; C A Lopes
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

4.  Immunoflow cytometry and cell block immunohistochemistry in the FNA diagnosis of lymphoma: a review of 73 consecutive cases.

Authors:  F Mayall; M Dray; D Stanley; B Harrison; R Allen
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

5.  Fine needle aspiration cytology in the diagnosis of uncommon types of lymphoma.

Authors:  F Mayall; A Darlington; B Harrison
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

6.  Fine needle aspiration cytology in the investigation on non-Hodgkin's lymphoma.

Authors:  M D Jeffers; J Milton; R Herriot; M McKean
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

7.  Fine needle aspiration cytology diagnosis of malignant lymphoma and reactive lymphoid hyperplasia.

Authors:  C J Stewart; J A Duncan; M Farquharson; J Richmond
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

8.  Flow cytometric immunophenotyping and cell block immunocytochemistry in the diagnosis of primary Non-Hodgkin's Lymphoma by fine-needle aspiration: Experience from a tertiary care center.

Authors:  Tuhin Paul; Upasana Gautam; Arvind Rajwanshi; Ashim Das; Amita Trehan; Pankaj Malhotra; Radhika Srinivasan
Journal:  J Cytol       Date:  2014-07       Impact factor: 1.000

9.  Contribution of Immunocytochemistry to the Diagnosis of Usual and Unusual Lymphoma Cases.

Authors:  Dilip K Das
Journal:  J Cytol       Date:  2018 Jul-Sep       Impact factor: 1.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.